DailyDoctor Archive Specialties Get app
Back to the 26 October 2026 edition

Clinical update · 01 of 05

Two hearing aids gave somewhat more benefit than one in age-related hearing loss

Offer two aids for symmetrical age-related loss where affordable, but one is far better than none.

Design
Two-centre, single-blinded parallel-group randomised trial
Population
275 adults aged ≥50 with age-related hearing loss, new to hearing aids
Primary outcome
Change in APHAB global score at 3 months
Effect
19.7 bilateral vs 14.4 unilateral; difference 5.3 points (95% CI 1.8–8.8)

This single-blinded randomised trial at two US university audiology clinics assigned 275 adults aged 50 or over with age-related hearing loss, new to hearing aids, to a unilateral or bilateral fitting with receiver-in-the-canal aids. The primary outcome was benefit at three months on the Abbreviated Profile of Hearing Aid Benefit (APHAB), a self-report scale.

Both groups improved meaningfully. Benefit was larger with two aids (mean 19.7 vs 14.4 points), a difference of about 5.3 points (95% CI 1.8 to 8.8). The authors note that this is statistically clear but may sit near or below the threshold most clinicians would call clinically important.

For most patients with symmetrical loss, bilateral fitting remains the sensible default where affordable. Where cost decides whether someone gets any aid at all, one well-fitted aid still gave substantial benefit, and is far better than none.

  • Offer bilateral fitting as the default for symmetrical age-related hearing loss where affordable.
  • If cost is the barrier, recommend a single aid rather than no aid; it still gave clear benefit.
  • Fit the better-candidate ear first when only one aid is possible, guided by audiometry and patient preference.
  • Review at about three months to check use, fit and benefit.
  • Revisit a second aid later if the first is used and valued.

Why it matters

It gives trial evidence for a routine choice that has largely rested on convention and cost.

Don't overread it

The extra benefit of the second aid was statistically clear but may not be clinically meaningful for everyone.

The statistics, in plain English

A 5-point difference on the APHAB, with an interval from about 2 to 9 points, is reliably greater than zero. Whether 5 points matters to an individual is less certain; both groups improved by more than 14 points, which is the larger effect.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

otologypaedentsleepairway

Tomorrow morning, before your first patient

One edition a day for ent & head and neck surgery, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app